Illumina Buyback
OLI recorded this information on 11/2/2015
Company:
Illumina
Buyback:
ILMN buyback
$Amount Authorized:
$250,000,000
Buyback Details:
Illumina (NASDAQ:ILMN) today announced that its Board of Directors has authorized the company to repurchase, on a discretionary basis, up to $250 million of its outstanding common shares in the open market or in privately negotiated transactions, subject to market conditions and other factors. The company also announced the completion of the existing discretionary authorization of $96 million that was repurchased since the company reported earnings on October 20th.
Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co.'s products and services enable the adoption of genomic solutions in research and clinical settings. Co.'s principal products, services, and technologies are: sequencing, which includes Deoxyribonucleic acid (DNA) sequencing, a process of determining the order of nucleotide bases (A, C, G, or T) in a DNA sample; arrays, which are used for a range of DNA and RNA analysis applications; consumables, which Co. has developed various library preparation and sequencing kits; and services, which provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services.
ILMN SEC Filing Email Alerts Service
Open the ILMN Page at The Online Investor »
|
Open the ILMN Page at The Online Investor (in a new window) »
Free ILMN Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (2.78 out of 4) 16th percentile
(ranked lower than approx. 84% of all stocks covered)
Analysts' Target Price: ILMN Stock Forecast Based on Zacks ABR data; powered by Xignite |